{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:59:11Z","timestamp":1791838751442,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ad.2025.104544","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:34:31Z","timestamp":1765211671000},"page":"104544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-0952","authenticated-orcid":false,"given":"L.","family":"Puig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vilarrasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"de la Cueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"L\u00f3pez-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2025.104544_bib0140","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2025.104544_bib0145","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s13555-022-00881-0","article-title":"Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment","volume":"13","author":"Rivera-D\u00edaz","year":"2023","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2025.104544_bib0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ad.2023.10.022","article-title":"Approach to the epidemiology, disease management, and current challenges in the management of generalized pustular psoriasis through a survey conducted among Spanish dermatologists","volume":"115","author":"Vilarrasa","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2025.104544_bib0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40257-021-00654-z","article-title":"Clinical course and characteristics of generalized pustular psoriasis","volume":"23","author":"Choon","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0160","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaad.2021.06.008","article-title":"Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan","volume":"86","author":"Miyachi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ad.2022.09.012","article-title":"Epidemiology and geographic distribution of generalized pustular psoriasis in Spain: a national population-based study of hospital admissions from 2016 to 2020","volume":"114","author":"Montero-Vilchez","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2025.104544_bib0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40257-021-00658-9","article-title":"Treatment options and goals for patients with generalized pustular psoriasis","volume":"23","author":"Krueger","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/09546634.2019.1682502","article-title":"Review of treatments for generalized pustular psoriasis","volume":"32","author":"Kearns","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2025.104544_bib0180","article-title":"Spesolimab for the treatment of generalized pustular psoriasis flares: an observational, retrospective, and multicenter study of effectiveness and safety in real-world clinical practice","author":"Canal-Garcia","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0185","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/1346-8138.14523","article-title":"Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP","volume":"45","author":"Fujita","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0190","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jdv.18851","article-title":"Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management","volume":"37","author":"Puig","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2025.104544_bib0195","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamadermatol.2024.0915","article-title":"International consensus definition and diagnostic criteria for generalized pustular psoriasis from the international psoriasis council","volume":"160","author":"Choon","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0200","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaad.2023.09.080","article-title":"Generalized pustular psoriasis: a consensus statement from the National Psoriasis Foundation","volume":"90","author":"Armstrong","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0205","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of spesolimab for generalized pustular psoriasis","volume":"385","author":"Bachelez","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2025.104544_bib0210","unstructured":"Spevigo Summary of Product Characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/spevigo-epar-product-information_en.pdf. Accessed 20 February 2025."},{"key":"10.1016\/j.ad.2025.104544_bib0215","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s13555-024-01230-z","article-title":"Current treatments for generalized pustular psoriasis: a narrative summary of a systematic literature search","volume":"14","author":"Puig","year":"2024","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2025.104544_bib0220","unstructured":"Acuerdos de la Comisi\u00f3n Interministerial de Precios de los Medicamentos. Sesi\u00f3n 243 de 21 de febrero de 2024. Available from: https:\/\/www.sanidad.gob.es\/areas\/farmacia\/precios\/comisionInteministerial\/acuerdosNotasInformativas\/docs\/ACUERDOS_CIPM_243.pdf. Accessed 20 February 2025."},{"key":"10.1016\/j.ad.2025.104544_bib0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jaad.2023.02.040","article-title":"Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study","volume":"89","author":"Elewski","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0230","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jdv.19935","article-title":"The role of interleukin-36 in health and disease states","volume":"38","author":"Sugiura","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2025.104544_bib0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaad.2023.09.078","article-title":"Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation","volume":"90","author":"Hackley","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0240","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/bjd\/ljae491","article-title":"Global Delphi consensus on treatment goals for generalised pustular psoriasis","volume":"192","author":"Barker","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2025.104544_bib0245","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(23)01378-8","article-title":"Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial","volume":"402","author":"Morita","year":"2023","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ad.2025.104544_bib0250","first-page":"778","article-title":"A non-interventional, multicenter study to characterize the socio-demographics, clinical characteristics, and management of generalized pustular psoriasis patients in Spain: IMPULSE study","volume":"240","author":"Puig","year":"2024","journal-title":"Dermatol Basel Switz"},{"key":"10.1016\/j.ad.2025.104544_bib0255","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13555-021-00504-0","article-title":"Spesolimab, an anti-interleukin-36 receptor antibody, in patients with palmoplantar pustulosis: results of a phase IIa, multicenter, double-blind, randomized, placebo-controlled pilot study","volume":"11","author":"Mrowietz","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2025.104544_bib0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jdv.16980","article-title":"Immunogenicity of biologic therapies in psoriasis: myths, facts and a suggested approach","volume":"35","author":"Tsakok","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2025.104544_bib0265","unstructured":"Spevigo(R)(spesolimab-sbzo) injection, for subcutaneous or intravenous use. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761244s003lbl.pdf. Accessed 20 February 2025."},{"key":"10.1016\/j.ad.2025.104544_bib0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40265-023-01988-0","article-title":"Spesolimab for the treatment of generalized pustular psoriasis","volume":"84","author":"Bernardo","year":"2024","journal-title":"Drugs"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025008208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731025008208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:42:08Z","timestamp":1781188928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731025008208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0001731025008208"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2025.104544","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2025.104544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104544"}}